Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | KDM4A | O75164 | 12/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 12/20 | 0.41 |
| ▸ | KDM5A | P29375 | 1/20 | 0.41 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.41 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.41 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28027517 | 0.98 | ALDH1A1 (0.43) | ALDH1A1TSHRKDM4AKDM4CKDM5A | |
| SCHEMBL15710764 | 0.93 | HTR2A (0.43) | ALDH1A1TSHRKDM4AKDM4CKDM5A | |
| SCHEMBL15711311 | 0.91 | HTR2A (0.42) | ALDH1A1TSHRKDM4AKDM4CKDM5A | |
| SCHEMBL2333725 | 0.82 | HTR2A (0.39) | ALDH1A1TSHRKDM4AKDM4CHTR2A | |
| SCHEMBL25468996 | 0.82 | LTA4H (0.50) | ALDH1A1TSHRKDM4AKDM4CKDM5A | |
| SCHEMBL8062393 | 0.82 | LTA4H (0.50) | ALDH1A1TSHRKDM4AKDM4CKDM5A | |
| SCHEMBL11226698 | 0.80 | ALDH1A1 (0.40) | ALDH1A1TSHRKDM4AKDM4CKDM5A | |
| SCHEMBL881063 | 0.80 | NOS2 (0.58) | TSHR | |
| SCHEMBL19198715 | 0.80 | NOS3 (0.33) | ALDH1A1KDM4AKDM4CPHF8KDM2A | |
| SCHEMBL14610975 | 0.80 | ACE2 (0.50) | ALDH1A1TSHRKDM4AKDM4CKDM5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9725477-B2 | Platinum compounds of malonic acid derivative having leaving group containing amino or alkylamino | BEIJING FSWELCOME TECHNOLOGY DEVELOPMENT CO., LTD (CN) | 2017-08-08 | — | — | US | disclosed |
| US-20150368281-A1 | Platinum Compounds Of Malonic Acid Derivative Having Leaving Group Containing Amino Or Alkylamino | BEIJING FSWELCOME TECHNOLOGY DEVELOPMENT CO., LTD (CN) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368281-A1 | Platinum Compounds Of Malonic Acid Derivative Having Leaving Group Containing Amino Or Alkylamino | SLC7A1, ME3, SLC7A5 | ALDH1A1 246/4885TSHR 4501/4885KDM4A 3454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.